OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.010
+0.160 (8.65%)
At close: May 13, 2026, 4:00 PM EDT
2.032
+0.022 (1.09%)
After-hours: May 13, 2026, 7:58 PM EDT
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$325,157
Profits / Employee
-$609,955
Market Cap
291.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 89 | -25 | -21.93% |
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Sep 30, 2022 | 93 | 23 | 32.86% |
| Jun 30, 2022 | 87 | 17 | 24.29% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Sep 30, 2021 | 70 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Voyager Therapeutics | 141 |
| Adagene | 128 |
| Arcturus Therapeutics Holdings | 111 |
| Orchestra BioMed Holdings | 86 |
| Keros Therapeutics | 78 |
| Cartesian Therapeutics | 75 |
| Milestone Pharmaceuticals | 38 |
OABI News
- 6 days ago - OmniAb reports Q1 EPS (6c), consensus (10c) - TheFly
- 6 days ago - OmniAb raises FY26 revenue view to $28M-$33M, consensus $28.0M - TheFly
- 6 days ago - OmniAb Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - OmniAb Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
- 19 days ago - OmniAb to Participate in Three Upcoming Investor Conferences - Business Wire
- 22 days ago - OmniAb to Report First Quarter 2026 Financial Results on May 7 - Business Wire
- 2 months ago - OmniAb Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - OmniAb reports Q4 EPS (11c), consensus (9c) - TheFly